• Home
  • >
  • Aarti Drugs Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/aarti-drugs-ltd.png Logo

Aarti Drugs Ltd Financial Statement

Aarti Drugs Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue560.64539.89578.28
Operating Expense490.47478.47512.12
Net Profit36.1431.6234.58
Net Profit Margin6.455.865.98
Earning Per Share3.933.443.75
EBIDTA71.6760.9264.91
Effective Tax Rate21.5217.516.63

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Aarti Drugs Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual2,716.052,488.652,154.78
Operating Expenses Annual2,410.452,159.211,717.67
Operating Profit Annual307.8340.75441.85
Interest Annual33.2920.7522.96
Depreciation47.6746.9445.33
Net Profit Annual166.31205.04280.41
Tax Annual57.8264.9688.62

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Aarti Drugs Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning21.618.816.77
Cash Flow from Operations134.270.41154.95
Cash Flow from Investing-163.97-149.64-71.78
Cash Flow from Financing16.5492.03-81.13
Cash Flow at the End8.3821.618.81

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Aarti Drugs Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)11.4713.8220.66
PBIT Margin (%)9.6211.8118.34
PBT Margin (%)9.3411.2617.55
Net PROFIT Margin (%)6.128.6613.46
Return On Networth / Equity (%)14.9321.0335.81
Return On Networth /Employed(%)15.2920.3333.38
Return On Assets (%)9.7314.924.49
Total Debt / Equity(X)0.510.470.48
Asset Turnover Ratio (%)1.591.721.82

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Aarti Drugs Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual676.23689.93665.4
Total Current Assets Annual1,492.351,393.371,056.8
Non Current Assets Annual929.05814.59709.22
Total Shareholders Funds Annual1,192.431,036.36913.42
Total Assets Annual2,421.42,207.961,766.01

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Aarti Drugs Ltd Earning Calls
Mar 2024
EPS beaten by 0.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Aarti Drugs Ltd has a market capitalization of 3,988.6 Cr. Value Research classifies it as a Mid-Cap company.

Yes, Aarti Drugs Ltd is debt-free with a debt-to-equity ratio of 0.44.

In FY 2023, Aarti Drugs Ltd recorded a total revenue of approximately 2,528.58 Cr marking a significant milestone in the company's financial performance.

Aarti Drugs Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.0% and 0.0% annually, respectively..

Aarti Drugs Ltd's current PE ratio is 23.27.

Aarti Drugs Ltd's ROCE averaged 15.7% from the FY ending March 2022 to 2024, with a median of 14.6%. It peaked at 18.3% in March 2022, reflecting strong capital efficiency over the period..

Aarti Drugs Ltd's latest EBIT is Rs. 269.05 Cr, surpassing the average EBIT of Rs. 272.41 Cr over the 5 years..